Clinical performance is complex and often involves multi-systematic stresses. Early identification and standardized clinical treatment are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of the Bernard-Soulier treatment regimen require individualized development, typically including drug therapy, rehabilitation interventions, regular follow-up, and multi-dimensional management. In recent years, significant improvements have been made to many previously difficult-to-treat blood tumour diseases with the development of targeted therapy, immune-regulatory therapy, and precision medicine.
Treatment requires close monitoring and timely adjustment of therapeutic efficacy and adverse reactions according to changing conditions. Multidisciplinary collaboration (MDT) is particularly important in the management of the Bernard-Soulier syndrome. The platform serves the China International Medical Service System, which combines a team of authoritative experts at home and abroad in the field of blood oncology, to provide the following services to patients: 1.
Remote pre-diagnosis: pre-examination of medical history, precise diagnostic directions and medical advice by a team of experts; 2. Interviews in China: arranging face-to-face diagnosis with authoritative experts, developing personalized treatment programs; 3. Full-service: providing one-stop services: providing medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects. Support for remote pre-diagnosis, visiting interviews, full translation and escort.